ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $65,000 | +47.7% | 1,039 | 0.0% | 0.00% | – |
| Q1 2020 | $44,000 | -12.0% | 1,039 | -3.3% | 0.00% | – |
| Q4 2019 | $50,000 | +2.0% | 1,074 | 0.0% | 0.00% | – |
| Q3 2019 | $49,000 | -22.2% | 1,074 | 0.0% | 0.00% | – |
| Q2 2019 | $63,000 | -92.9% | 1,074 | -94.6% | 0.00% | -100.0% |
| Q1 2019 | $893,000 | +15.2% | 19,913 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $775,000 | -15.5% | 19,910 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $917,000 | +5.4% | 19,920 | -0.2% | 0.00% | 0.0% |
| Q2 2018 | $870,000 | +535.0% | 19,951 | +474.8% | 0.00% | – |
| Q1 2018 | $137,000 | +71.2% | 3,471 | +47.5% | 0.00% | – |
| Q4 2017 | $80,000 | +33.3% | 2,353 | 0.0% | 0.00% | – |
| Q3 2017 | $60,000 | +50.0% | 2,353 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | – | 2,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |